Based on the results from this study, we hypothesize that so far undefined RA sub-phenotype(s) not responding to anti-TNF treatment are characterized by increased NLRP3-inflammasome activation and increased IL–1β/IL–18 production. The gene discussed is TNF; the disease is rheumatoid arthritis.